261 related articles for article (PubMed ID: 34866847)
1. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.
Tohra S; Duseja A; Taneja S; Kalra N; Gorsi U; Behera A; Kaman L; Dahiya D; Sahu S; Sharma B; Singh V; Dhiman RK; Chawla Y
J Clin Exp Hepatol; 2021; 11(6):682-690. PubMed ID: 34866847
[TBL] [Abstract][Full Text] [Related]
2. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
Mukund A; Vats P; Jindal A; Patidar Y; Sarin SK
J Clin Exp Hepatol; 2020; 10(6):563-573. PubMed ID: 33311893
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Nonalcoholic Steatohepatitis- Versus Viral Hepatitis- and Alcohol-Related Liver Disease-Related Hepatocellular Carcinoma.
Hester CA; Rich NE; Singal AG; Yopp AC
J Natl Compr Canc Netw; 2019 Apr; 17(4):322-329. PubMed ID: 30959469
[TBL] [Abstract][Full Text] [Related]
5. Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
Zhuang BW; Li W; Wang W; Li B; Lu MD; Kuang M; Xie XH; Xie XY
Eur Radiol; 2021 Jul; 31(7):5379-5389. PubMed ID: 33404697
[TBL] [Abstract][Full Text] [Related]
6. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
[TBL] [Abstract][Full Text] [Related]
8. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
10. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
Wong KM; Yeh ML; Chuang SC; Wang LY; Lin ZY; Chen SC; Tsai JF; Wang SN; Kuo KK; Dai CY; Yu ML; Lee KT; Chuang WL
Indian J Gastroenterol; 2013 Jul; 32(4):253-7. PubMed ID: 22932964
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
14. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
Gui CH; Baey S; D'cruz RT; Shelat VG
Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients.
Hocquelet A; Balageas P; Laurent C; Blanc JF; Frulio N; Salut C; Cassinotto C; Saric J; Possenti L; Bernard PH; Montaudon M; Trillaud H
Int J Hyperthermia; 2015; 31(7):749-57. PubMed ID: 26365503
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
Ali MAM; Harmsen WS; Morsy KH; Galal GMK; Therneau TM; Roberts LR
BMC Cancer; 2022 Feb; 22(1):221. PubMed ID: 35227234
[TBL] [Abstract][Full Text] [Related]
18. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
[TBL] [Abstract][Full Text] [Related]
19. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials.
Jia Z; Zhang H; Li N
J Gastroenterol Hepatol; 2021 Jul; 36(7):1769-1777. PubMed ID: 33569810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
